Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU
Status:
RECRUITING
Trial end date:
2025-12-10
Target enrollment:
Participant gender:
Summary
Renal dysfunction is a frequent complication in patients admitted to intensive care units (ICUs), associated with high morbidity and mortality. Current therapeutic options to prevent this condition are limited and lack robust scientific evidence. This pilot study consists of a multicenter, blinded, randomized clinical trial, unprecedented in the literature to date, aiming to fill this knowledge gap and offer new therapeutic perspectives to improve renal outcomes in critically ill patients admitted to the ICU.